Bank OZK, based in Little Rock, Arkansas, has earned a strong position among regional banks through its focus on high-yield specialized real estate and corporate lending. The upcoming third quarter release comes at an important time as the bank works to balance repayments of older RESG loans with growth in Corporate & Institutional Banking activity. After two quarters of modest loan contraction, investors are looking for signs that overall balance sheet expansion is picking up again. A changing rate environment and higher operating costs have weighed on profitability compared with last year, so this report will test the durability of the bank’s earnings profile.
Wall Street forecasts for the quarter remain measured. Consensus points to EPS in the $1.43 to $1.45 range and revenue near $432 million to $437 million. That compares with record EPS of $1.59 and revenue around $450 million in the same quarter last year. The anticipated year-over-year decline reflects several headwinds, including lower net interest income as variable-rate loans reprice downward. In the second quarter of 2026, the bank posted EPS of $1.49, slightly ahead of estimates, while net interest margin widened by four basis points and deposit costs eased. Total loans, however, declined about 2% sequentially, driven largely by roughly $3 billion in RESG prepayments.
Investors will examine net interest margin, the cost of interest-bearing deposits, loan and deposit balances, the efficiency ratio, net charge-offs, and the allowance for credit losses. Bank OZK shares have historically reacted to both earnings surprises and management commentary on pipelines and credit trends. I also checked this using Tickeron’s AI Screener to see how the stock compares with peers in the regional banking space.
Investor sentiment appears cautious ahead of the report. Shares of Bank OZK have lagged in recent months, with some observers noting a negative post-earnings drift after the July 2026 results tied to ongoing questions about loan growth and margin pressure. The market is already pricing in lower profits than a year ago, which sets a lower bar for a positive surprise but increases the importance of forward-looking comments from management.
Potential risks include additional RESG prepayments, higher expenses, and any signs of credit weakness in commercial real estate or life science loans. On the positive side, faster originations in Corporate & Institutional Banking, stable margins, or stronger deposit growth could support the stock.
Several longer-term factors will influence Bank OZK’s path into 2027. Loan growth remains central, with management reiterating a mid-single-digit target for the full year and expecting improvement in the second half as Corporate & Institutional Banking activity strengthens and RESG repayments normalize. A return to positive loan growth in the third quarter would be a meaningful signal.
The direction of net interest margin and deposit costs also merits attention. Management has noted that deposit costs may rise modestly starting in the third and fourth quarters, potentially offsetting any stabilization in loan yields. How quickly the bank’s variable-rate loan book adjusts in the current rate environment will shape net interest income going forward.
Credit quality continues to be a key focus. The bank expects net charge-offs to stay below industry averages, supported by a higher allowance for credit losses. Discipline in the office and life science portfolios, along with capital actions such as the recently authorized share repurchases, will help shape the overall outlook.
When preparing for earnings seasons like this one, I often turn to Tickeron’s AI Screener to quickly compare Bank OZK with other regional banks on fundamentals, technical patterns, and volatility measures. The tool lets me apply custom filters across thousands of stocks and ETFs, helping surface relevant peers or breakout candidates ahead of catalyst events. It streamlines what used to be a manual process and provides a clearer view of how the stock fits within broader industry trends.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for OZK moved out of oversold territory on October 08, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 25 of the 32 cases the stock moved higher. This puts the odds of a move higher at 78%.
The Moving Average Convergence Divergence (MACD) for OZK just turned positive on October 14, 2026. Looking at past instances where OZK's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.
Following a +2.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where OZK advanced for three days, in 198 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
OZK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OZK as a result. In 50 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OZK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
The Aroon Indicator for OZK entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 10 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 28 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.847) is normal, around the industry mean (1.237). P/E Ratio (7.598) is within average values for comparable stocks, (13.122). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.190). Dividend Yield (0.042) settles around the average of (0.036) among similar stocks. P/S Ratio (3.077) is also within normal values, averaging (3.738).
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 51 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. OZK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks